Drug Profile
PF 217830
Alternative Names: PF-00217830; Pf-217830Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antipsychotics
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine D2 receptor agonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 27 Sep 2010 Discontinued - Phase-II for Schizophrenia in Eastern Europe (PO)
- 27 Sep 2010 Discontinued - Phase-II for Schizophrenia in India (PO)
- 27 Sep 2010 Discontinued - Phase-II for Schizophrenia in USA (PO)